SCHEMBL3355596

SCHEMBL3355596

Cn1cc(CCN2CCCC2)c2cc([N+](=O)[O-])ccc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.55
MEN1 O00255 1/20 0.55
LMNA P02545 1/20 0.55
CYP2D6 P10635 1/20 0.55
KMT2A Q03164 1/20 0.55
HRH3 Q9Y5N1 1/20 0.53
CDK2 P24941 3/20 0.48
PKM P14618 1/20 0.47
KCNJ1 P48048 2/20 0.46
KCNH2 Q12809 1/20 0.46
SIGMAR1 Q99720 2/20 0.45
CACNB4 O00305 1/20 0.45
CACNA1A O00555 1/20 0.45
CACNA1G O43497 1/20 0.45
CACNG3 O60359 1/20 0.45
CACNA1F O60840 1/20 0.45
CACNA1H O95180 1/20 0.45
CACNB3 P54284 1/20 0.45
CACNA2D1 P54289 1/20 0.45
CACNG7 P62955 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3355597 0.99 ALDH1A1 (0.57) ALDH1A1MEN1LMNACYP2D6KMT2A
SCHEMBL3351522 0.91 HTR6 (0.51) ALDH1A1MEN1LMNACYP2D6KMT2A
SCHEMBL2075237 0.90 HRH3 (0.53) ALDH1A1MEN1LMNACYP2D6KMT2A
SCHEMBL3352554 0.89 KMT2A (0.51) ALDH1A1MEN1LMNACYP2D6KMT2A
SCHEMBL3352978 0.89 CACNB4 (0.56) ALDH1A1MEN1LMNACYP2D6KMT2A
SCHEMBL3356257 0.88 CACNB4 (0.58) ALDH1A1MEN1LMNACYP2D6KMT2A
SCHEMBL9400557 0.81 MAPT (0.51) MEN1LMNAKMT2ACDK2CNR1
SCHEMBL3353450 0.80 HTR6 (0.62) ALDH1A1LMNACDK2PKMCACNB4
SCHEMBL3355292 0.80 HTR6 (0.59) MEN1LMNAKMT2ACDK2HTR7
SCHEMBL29540778 0.79 MAPT (0.53) MEN1LMNAKMT2ACDK2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2141163-A1 Substituted thiazolidinones, their production and utilisation as medicine Bayer Schering Pharma AG (DE) 2010-01-06 EP disclosed